0 Table of Contents |
1 Home Page |
2 Business Use Cases |
3 Domains Overview |
3.1 Analytical Procedures |
3.1.1 Analytical Procedures: synthetic data rendering - drug product |
3.1.2 Analytical Procedures: synthetic data rendering - drug substance |
3.2 Batch Analysis |
3.2.1 Batch Analysis: synthetic data rendering - drug product |
3.2.2 Batch Analysis: synthetic data rendering - drug substance |
3.3 Batch Formula |
3.3.1 Batch Formula: synthetic data rendering - drug product |
3.4 Batch/Lot Information |
3.4.1 Batch/Lot Information: synthetic data rendering - drug product |
3.4.2 Batch/Lot Information: synthetic data rendering - drug substance |
3.5 Compatibility |
3.5.1 Compatibility: synthetic data rendering - drug product |
3.6 Composition |
3.6.1 Composition: synthetic data rendering - drug product |
3.6.2 Composition: synthetic data rendering - drug substance |
3.7 Container Closure System |
3.7.1 Container Closure System: synthetic data rendering - drug product |
3.7.2 Container Closure System: synthetic data rendering - drug substance |
3.8 Drug Specification |
3.8.1 Drug Specification: synthetic data rendering - drug product |
3.8.2 Drug Specification: synthetic data rendering - drug substance |
3.9 Identification |
3.9.1 Identification: synthetic data rendering - drug product |
3.9.2 Identification: synthetic data rendering - drug product microbiological attributes |
3.9.3 Identification: synthetic data rendering - drug product excipients |
3.9.4 Identification: synthetic data rendering - drug substance general properties |
3.9.5 Identification: synthetic data rendering - drug substance characterisation, elucidation of structure |
3.10 Impurities |
3.10.1 Impurities: synthetic data rendering - drug product |
3.10.2 Impurities: synthetic data rendering - drug substance |
3.11 Manufacturing Process |
3.11.1 Manufacturing Process: synthetic data rendering - drug product |
3.11.2 Manufacturing Process: synthetic data rendering - drug substance |
3.12 Organizations |
3.12.1 Organizations: synthetic data rendering |
3.13 Process Validation |
3.13.1 Process Validation: synthetic data rendering - drug product |
3.13.2 Process Validation: synthetic data rendering - drug product, biologic |
3.13.3 Process Validation: synthetic data rendering - drug substance |
3.14 Stability Study |
3.14.1 Stability Study: synthetic data rendering - drug product |
3.14.2 Stability Study: synthetic data rendering - drug substance |
4 General Principles & Design |
5 Downloads |
6 Artifacts Summary |
6.1 Bundle - Analytical Procedure |
6.2 Bundle - Batch Analysis |
6.3 Bundle - Batch Formula |
6.4 Bundle - Product Batch Information |
6.5 Bundle - Substance Batch Information |
6.6 Bundle - Product Compatibility |
6.7 Bundle - Product Composition |
6.8 Bundle - Reference Standards |
6.9 Bundle - Container Closure System |
6.10 Bundle - Product Specification |
6.11 Bundle - Substance Specification |
6.12 Bundle - Drug Product |
6.13 Bundle - Product Microbiological Attributes |
6.14 Bundle - Product Excipients |
6.15 Bundle - Substance General Properties |
6.16 Bundle - Substance Characterization |
6.17 Bundle - Impurities |
6.18 Bundle - Manufacturing |
6.19 Bundle - Organizations |
6.20 Bundle - Process Validation |
6.21 Bundle - Stability |
6.22 Example: Bundle – Analytical Procedure, product |
6.23 Example: Bundle – Analytical Procedure, substance |
6.24 Example: Bundle – Batch Analysis, product |
6.25 Example: Bundle – Batch Analysis, substance |
6.26 Example: Bundle - Batch Formula |
6.27 Example: Bundle – Product Batch Information |
6.28 Example: Bundle – Substance Batch Information |
6.29 Example: Bundle – Product Compatibility |
6.30 Example: Bundle – Product Composition |
6.31 Example: Bundle – Reference Standards, substance |
6.32 Example: Bundle - Container Closure System, product |
6.33 Example: Bundle - Container Closure System, substance |
6.34 Example: Bundle – Product Specification |
6.35 Example: Bundle – Substance Specification |
6.36 Example: Bundle – Drug Product |
6.37 Example: Bundle – Product Microbiological Attributes |
6.38 Example: Bundle – Product Excipients |
6.39 Example: Bundle – Substance General Properties |
6.40 Example: Bundle – Substance Characterization |
6.41 Example: Bundle - Impurities, product |
6.42 Example: Bundle - Impurities, substance |
6.43 Example: Bundle - Manufacturing, product |
6.44 Example: Bundle - Manufacturing, substance |
6.45 Example: Bundle - Organizations |
6.46 Example: Bundle - Process Validation, product |
6.47 Example: Bundle - Process Validation, biologic product |
6.48 Example: Bundle - Process Validation, substance |
6.49 Example: Bundle – Stability, product |
6.50 Example: Bundle – Stability, substance |
6.51 ActivityDefinition - Test |
6.52 Composition - Drug |
6.53 DeviceDefinition - Drug |
6.54 DiagnosticReport - Drug Analysis |
6.55 DocumentReference - Drug |
6.56 Ingredient - Drug |
6.57 ManufacturedItemDefinition - Drug |
6.58 Medication - Batch Information |
6.59 MedicinalProductDefinition - Drug Product |
6.60 Observation - Test Result |
6.61 ObservationDefinition - Test Method |
6.62 Organization - Drug |
6.63 PackagedProductDefinition - Drug |
6.64 PlanDefinition - Drug |
6.65 Procedure - Drug |
6.66 Specimen - Drug |
6.67 SpecimenDefinition - Drug |
6.68 Substance - Drug |
6.69 SubstanceDefinition - Component Drug |
6.70 ActivityDefinition - Test - example 1 |
6.71 ActivityDefinition - Test - example 2 |
6.72 Composition - Drug - example, formulation |
6.73 Composition - Drug - example, risk |
6.74 DeviceDefinition - Drug - example |
6.75 DiagnosticReport - Drug Analysis - example, stability |
6.76 DocumentReference - Drug - example |
6.77 Ingredient - Drug - example |
6.78 ManufacturedItemDefinition - Drug - example 1 |
6.79 ManufacturedItemDefinition - Drug - example 2 |
6.80 Medication - Batch Information - example |
6.81 MedicinalProductDefinition - Drug Product - example |
6.82 Observation - Test Result - example 1 |
6.83 Observation - Test Result - example 2 |
6.84 ObservationDefinition - Test Method - example 1, longTerm25X |
6.85 ObservationDefinition - Test Method - example 2, Water |
6.86 Organization - Drug - example 1, manufacturer |
6.87 Organization - Drug - example 2, manufacturer |
6.88 Organization - Drug - example 3, packaging |
6.89 Organization - Drug - example 4, packaging |
6.90 Organization - Drug - example 5, testing lab |
6.91 PackagedProductDefinition - Drug - example |
6.92 PlanDefinition - Drug - example, validation protocol |
6.93 PlanDefinition - Drug - example, manufacturing plan |
6.94 PlanDefinition - Drug - example, drug specification |
6.95 PlanDefinition - Drug - example, manufacturing process |
6.96 PlanDefinition - Drug - example, stability study protocol |
6.97 Procedure - Drug - example 1 |
6.98 Procedure - Drug - example 2 |
6.99 Specimen - Drug - example |
6.100 SpecimenDefinition - Drug - example 1 |
6.101 SpecimenDefinition - Drug - example 2 |
6.102 SpecimenDefinition - Drug - example 3 |
6.103 Substance - Drug - example |
6.104 SubstanceDefinition - Component Drug - example 1 |
6.105 SubstanceDefinition - Component Drug - example 2 |
6.106 SubstanceDefinition - Component Drug - example 3 |
6.107 accelerated40X |
6.108 accelerated40Y |
6.109 accelerated40Z |
6.110 longTerm25Y |
6.111 longTerm25Z |
6.112 longTerm30X |
6.113 longTerm30Y |
6.114 Assay |
6.115 Degradation |
6.116 Description |
6.117 Identification |
6.118 Impurities |
6.119 Microbiological |
6.120 Uniformity |
6.121 observation-test-result-longterm25c-initial-1 |
6.122 observation-test-result-lt25c-i1-degradation-imp2 |
6.123 observation-test-result-lt25c-i1-degradation-imp3 |
6.124 observation-test-result-lt25c-i1-degradation-imp-total |
6.125 observation-test-result-lt25c-i1-degradation-imp-unspecified |
6.126 observation-test-result-lt25c-i1-microbiological |
6.127 observation-test-result-lt25c-i1-uniformity |
6.128 observation-test-result-lt25c-i1-water |
6.129 Extension - Actual Yield |
6.130 Extension - Actual Yield Unfiltered |
6.131 Extension - Batch Derived From |
6.132 Extension - Batch Designation |
6.133 Extension - Batch Number of Items |
6.134 Extension - Batch Number of Full Shelves |
6.135 Extension - Batch Number of Partial Shelves |
6.136 Extension - Batch Number of Vials |
6.137 Extension - Batch Release Date |
6.138 Extension - Batch Retest Date |
6.139 Extension - Batch Storage Duration |
6.140 Extension - Batch Substance Batch |
6.141 Extension - Container Orientation |
6.142 Extension - Formulation Number |
6.143 Extension - History of Process |
6.144 Extension - Impurity Origin |
6.145 Extension - Manufacturing Participant |
6.146 Extension - Manufacturing Process |
6.147 Extension - Medication Definition |
6.148 Extension - Novel Excipient |
6.149 Extension - Package Definition |
6.150 Extension - Packaging Date |
6.151 Extension - Packaging Site |
6.152 Extension - Plan Document Reference |
6.153 Extension - Process Parameters |
6.154 Extension - Process Step Scale |
6.155 Extension - Qualified Value Criticality |
6.156 Extension - Qualified Value Display |
6.157 Extension - Qualified Value Target |
6.158 Extension - Qualified Value Text |
6.159 Extension - Site Utilization |
6.160 Extension - Statistical Model |
6.161 Extension - Substance Property Parameter |
6.162 Extension - Substance Property Range |
6.163 Extension - Suitability For Use |
6.164 Extension - Target Fill Weight |
6.165 Extension - Test Comment |
6.166 Extension - Time Point Description |
6.167 Batch Designation |
6.168 Characterization Steps |
6.169 Closure Types |
6.170 Colors |
6.171 Container Orientations |
6.172 ISO Country two letter codes |
6.173 Device Properties |
6.174 Device Type |
6.175 Diagram Types |
6.176 Equipment Classes |
6.177 Goal Priority |
6.178 Grades |
6.179 Impurity Origins |
6.180 Impurity Types |
6.181 Ingredient Function |
6.182 Manufactured Item Property |
6.183 Manufacturing Participant Role |
6.184 Manufacturing Step |
6.185 Manufacturing Step Scale |
6.186 MedicinalProduct Characteristic Type |
6.187 Medicine Dose Form EDQM |
6.188 Medicine Route of Administration EDQM |
6.189 Package Property |
6.190 Pharmaceutical Organization Type |
6.191 Plan Type |
6.192 Process Validation Procedure |
6.193 Process Parameter |
6.194 Product Name Type |
6.195 Product Site Utilization |
6.196 Qualified Value Criticality |
6.197 Report Type |
6.198 Specification Type |
6.199 Substance Property |
6.200 Substance Property Value |
6.201 Test Method |
6.202 Test Category |
6.203 Time Point Description |
6.204 Batch Designation Codes |
6.205 Closure Type Codes |
6.206 Container Orientation Codes |
6.207 Device Type - example |
6.208 Goal Priority - example |
6.209 Example Local Codes - Drug |
6.210 Manufactured Item Property - example |
6.211 Product Name Type - example |
6.212 Specification Type - example |
6.213 Substance Property - example |
6.214 Substance Property Value - example |
6.215 Device Property Codes |
6.216 Diagram Type Codes |
6.217 Drug Substance or Product Color Codes |
6.218 Impurity Origin Codes |
6.219 Impurity Type Codes |
6.220 Ingredient Function Codes |
6.221 Manufacturing Participant Role Codes |
6.222 Manufacturing Step Scale Codes |
6.223 Manufacturing Step Codes |
6.224 Observation Qualified Value Criticality Codes |
6.225 Package Grade Codes |
6.226 Package Property Codes |
6.227 Pharmaceutical Manufacturing Equipment Class Codes |
6.228 Pharmaceutical Organization Type Codes |
6.229 Pharmaceutical Plan Type Codes |
6.230 Pharmaceutical Report Type Codes |
6.231 Pharmaceutical Test Category Codes |
6.232 Process Parameter Codes |
6.233 Product Site Utilization Type Codes |
6.234 Structure Characterization Technique Codes |
6.235 Time Point Description Codes |